Explore the cutting-edge research on Cancer Drug Resistance with this comprehensive hardcover volume from Springer, part of the esteemed Cancer Drug Discovery and Development series. Published in 2006, this essential reference delves deep into the complexities of how cancer cells evade therapeutic treatments. It’s an indispensable resource for researchers, oncologists, and students seeking to understand the mechanisms behind drug resistance and to develop more effective cancer therapies. “Cancer Drug Resistance (HB)” offers 617 pages of detailed insights, making it a cornerstone for advancing cancer treatment strategies. Discover the latest scientific advancements and strategies to overcome therapeutic challenges at The Bookish Owl.